Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

08/11/2023 04:30

Nov 8 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.17               36.82            73.10    
                 (-1.8 pct)          (-2.0 pct)       (+0.2 pct)  
  Operating          5.51                8.21             7.60    
                 (-32.8 pct)         (-9.2 pct)       (-5.0 pct)  
  Recurring          5.72                8.56             8.00    
                 (-33.1 pct)         (-7.9 pct)       (-8.3 pct)  
  Net                4.07                5.96             6.70    
                 (-31.8 pct)         (-11.3 pct)      (+23.2 pct) 
  EPS            108.18 yen          158.34 yen       176.92 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div         75.00 yen           75.00 yen                   
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T